<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-24T14:51:49.233998",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "GluMind",
    "Multimodal Learning",
    "Attention Mechanism",
    "Knowledge Retention"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "GluMind": 0.8,
    "Multimodal Learning": 0.85,
    "Attention Mechanism": 0.82,
    "Knowledge Retention": 0.78
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "GluMind",
        "canonical": "GluMind",
        "aliases": [],
        "category": "unique_technical",
        "rationale": "GluMind is a novel framework specifically designed for blood glucose forecasting, making it a unique technical contribution.",
        "novelty_score": 0.85,
        "connectivity_score": 0.65,
        "specificity_score": 0.9,
        "link_intent_score": 0.8
      },
      {
        "surface": "Transformer-based multimodal framework",
        "canonical": "Multimodal Learning",
        "aliases": [
          "multimodal framework"
        ],
        "category": "specific_connectable",
        "rationale": "The use of a transformer-based multimodal framework aligns with the concept of Multimodal Learning, which is trending and relevant for linking.",
        "novelty_score": 0.55,
        "connectivity_score": 0.88,
        "specificity_score": 0.78,
        "link_intent_score": 0.85
      },
      {
        "surface": "Cross-attention",
        "canonical": "Attention Mechanism",
        "aliases": [
          "cross attention"
        ],
        "category": "specific_connectable",
        "rationale": "Cross-attention is a specific type of attention mechanism, which is a key concept in neural network models.",
        "novelty_score": 0.5,
        "connectivity_score": 0.9,
        "specificity_score": 0.8,
        "link_intent_score": 0.82
      },
      {
        "surface": "Knowledge retention technique",
        "canonical": "Knowledge Retention",
        "aliases": [
          "knowledge retention module"
        ],
        "category": "unique_technical",
        "rationale": "Knowledge retention is a unique feature of the GluMind model, enhancing its ability to maintain learned information over time.",
        "novelty_score": 0.7,
        "connectivity_score": 0.6,
        "specificity_score": 0.85,
        "link_intent_score": 0.78
      }
    ],
    "ban_list_suggestions": [
      "blood glucose forecasting",
      "predictive performance",
      "experimental results"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "GluMind",
      "resolved_canonical": "GluMind",
      "decision": "linked",
      "scores": {
        "novelty": 0.85,
        "connectivity": 0.65,
        "specificity": 0.9,
        "link_intent": 0.8
      }
    },
    {
      "candidate_surface": "Transformer-based multimodal framework",
      "resolved_canonical": "Multimodal Learning",
      "decision": "linked",
      "scores": {
        "novelty": 0.55,
        "connectivity": 0.88,
        "specificity": 0.78,
        "link_intent": 0.85
      }
    },
    {
      "candidate_surface": "Cross-attention",
      "resolved_canonical": "Attention Mechanism",
      "decision": "linked",
      "scores": {
        "novelty": 0.5,
        "connectivity": 0.9,
        "specificity": 0.8,
        "link_intent": 0.82
      }
    },
    {
      "candidate_surface": "Knowledge retention technique",
      "resolved_canonical": "Knowledge Retention",
      "decision": "linked",
      "scores": {
        "novelty": 0.7,
        "connectivity": 0.6,
        "specificity": 0.85,
        "link_intent": 0.78
      }
    }
  ]
}
-->

# GluMind: Multimodal Parallel Attention and Knowledge Retention for Robust Cross-Population Blood Glucose Forecasting

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250924|20250924]] [[categories/cs.LG|cs.LG]]
**PDF**: [Download](https://arxiv.org/pdf/2509.18457.pdf)
**Category**: cs.LG
**Published**: 2025-09-24
**ArXiv ID**: [2509.18457](https://arxiv.org/abs/2509.18457)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-23/Estimating Clinical Lab Test Result Trajectories from PPG using Physiological Foundation Model and Patient-Aware State Space Model -- a UNIPHY+ Approach_20250923|Estimating Clinical Lab Test Result Trajectories from PPG using Physiological Foundation Model and Patient-Aware State Space Model -- a UNIPHY+ Approach]] (82.8% similar)
- [[2025-09-17/Personalization on a Budget_ Minimally-Labeled Continual Learning for Resource-Efficient Seizure Detection_20250917|Personalization on a Budget: Minimally-Labeled Continual Learning for Resource-Efficient Seizure Detection]] (82.3% similar)
- [[2025-09-19/UMind_ A Unified Multitask Network for Zero-Shot M/EEG Visual Decoding_20250919|UMind: A Unified Multitask Network for Zero-Shot M/EEG Visual Decoding]] (82.0% similar)
- [[2025-09-23/A Unified AI Approach for Continuous Monitoring of Human Health and Diseases from Intensive Care Unit to Home with Physiological Foundation Models (UNIPHY+)_20250923|A Unified AI Approach for Continuous Monitoring of Human Health and Diseases from Intensive Care Unit to Home with Physiological Foundation Models (UNIPHY+)]] (81.6% similar)
- [[2025-09-23/Toward Affordable and Non-Invasive Detection of Hypoglycemia_ A Machine Learning Approach_20250923|Toward Affordable and Non-Invasive Detection of Hypoglycemia: A Machine Learning Approach]] (81.4% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ”— Specific Connectable**: [[keywords/Multimodal Learning|Multimodal Learning]], [[keywords/Attention Mechanism|Attention Mechanism]]
**âš¡ Unique Technical**: [[keywords/GluMind|GluMind]], [[keywords/Knowledge Retention|Knowledge Retention]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.18457v1 Announce Type: new 
Abstract: This paper proposes GluMind, a transformer-based multimodal framework designed for continual and long-term blood glucose forecasting. GluMind devises two attention mechanisms, including cross-attention and multi-scale attention, which operate in parallel and deliver accurate predictive performance. Cross-attention effectively integrates blood glucose data with other physiological and behavioral signals such as activity, stress, and heart rate, addressing challenges associated with varying sampling rates and their adverse impacts on robust prediction. Moreover, the multi-scale attention mechanism captures long-range temporal dependencies. To mitigate catastrophic forgetting, GluMind incorporates a knowledge retention technique into the transformer-based forecasting model. The knowledge retention module not only enhances the model's ability to retain prior knowledge but also boosts its overall forecasting performance. We evaluate GluMind on the recently released AIREADI dataset, which contains behavioral and physiological data collected from healthy people, individuals with prediabetes, and those with type 2 diabetes. We examine the performance stability and adaptability of GluMind in learning continuously as new patient cohorts are introduced. Experimental results show that GluMind consistently outperforms other state-of-the-art forecasting models, achieving approximately 15% and 9% improvements in root mean squared error (RMSE) and mean absolute error (MAE), respectively.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì€ ì§€ì†ì ì´ê³  ì¥ê¸°ì ì¸ í˜ˆë‹¹ ì˜ˆì¸¡ì„ ìœ„í•œ GluMindë¼ëŠ” íŠ¸ëœìŠ¤í¬ë¨¸ ê¸°ë°˜ ë‹¤ì¤‘ ëª¨ë‹¬ í”„ë ˆì„ì›Œí¬ë¥¼ ì œì•ˆí•©ë‹ˆë‹¤. GluMindëŠ” êµì°¨ ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ê³¼ ë‹¤ì¤‘ ìŠ¤ì¼€ì¼ ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ì„ ë³‘í–‰í•˜ì—¬ ì •í™•í•œ ì˜ˆì¸¡ ì„±ëŠ¥ì„ ì œê³µí•©ë‹ˆë‹¤. êµì°¨ ì£¼ì˜ëŠ” í˜ˆë‹¹ ë°ì´í„°ì™€ í™œë™, ìŠ¤íŠ¸ë ˆìŠ¤, ì‹¬ë°•ìˆ˜ ë“±ì˜ ìƒë¦¬ì  ë° í–‰ë™ì  ì‹ í˜¸ë¥¼ íš¨ê³¼ì ìœ¼ë¡œ í†µí•©í•˜ì—¬ ë‹¤ì–‘í•œ ìƒ˜í”Œë§ ì†ë„ì˜ ë¬¸ì œë¥¼ í•´ê²°í•©ë‹ˆë‹¤. ë‹¤ì¤‘ ìŠ¤ì¼€ì¼ ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ì€ ì¥ê¸°ì ì¸ ì‹œê°„ ì˜ì¡´ì„±ì„ í¬ì°©í•©ë‹ˆë‹¤. ë˜í•œ, GluMindëŠ” ì§€ì‹ ë³´ì¡´ ê¸°ë²•ì„ ë„ì…í•˜ì—¬ ëª¨ë¸ì˜ ì´ì „ ì§€ì‹ ìœ ì§€ ëŠ¥ë ¥ì„ í–¥ìƒì‹œí‚µë‹ˆë‹¤. AIREADI ë°ì´í„°ì…‹ì„ ì‚¬ìš©í•œ ì‹¤í—˜ ê²°ê³¼, GluMindëŠ” ë‹¤ë¥¸ ìµœì‹  ì˜ˆì¸¡ ëª¨ë¸ë³´ë‹¤ ì•½ 15%ì˜ RMSEì™€ 9%ì˜ MAE ê°œì„ ì„ ë‹¬ì„±í•˜ë©° ì„±ëŠ¥ì˜ ì•ˆì •ì„±ê³¼ ì ì‘ì„±ì„ ì…ì¦í–ˆìŠµë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. GluMindëŠ” ì§€ì†ì ì´ê³  ì¥ê¸°ì ì¸ í˜ˆë‹¹ ì˜ˆì¸¡ì„ ìœ„í•œ íŠ¸ëœìŠ¤í¬ë¨¸ ê¸°ë°˜ ë©€í‹°ëª¨ë‹¬ í”„ë ˆì„ì›Œí¬ë¥¼ ì œì•ˆí•©ë‹ˆë‹¤.
- 2. ì´ ëª¨ë¸ì€ êµì°¨ ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ê³¼ ë‹¤ì¤‘ ìŠ¤ì¼€ì¼ ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ì„ ë³‘ë ¬ë¡œ ìš´ì˜í•˜ì—¬ ì˜ˆì¸¡ ì„±ëŠ¥ì„ í–¥ìƒì‹œí‚µë‹ˆë‹¤.
- 3. ì§€ì‹ ìœ ì§€ ê¸°ë²•ì„ ë„ì…í•˜ì—¬ ì´ì „ ì§€ì‹ì„ ë³´ì¡´í•˜ê³  ì „ë°˜ì ì¸ ì˜ˆì¸¡ ì„±ëŠ¥ì„ í–¥ìƒì‹œí‚µë‹ˆë‹¤.
- 4. AIREADI ë°ì´í„°ì…‹ì„ ì‚¬ìš©í•œ ì‹¤í—˜ ê²°ê³¼, GluMindëŠ” RMSEì™€ MAEì—ì„œ ê°ê° ì•½ 15%ì™€ 9%ì˜ ì„±ëŠ¥ í–¥ìƒì„ ë³´ì˜€ìŠµë‹ˆë‹¤.
- 5. GluMindëŠ” ìƒˆë¡œìš´ í™˜ì ì§‘ë‹¨ì´ ë„ì…ë  ë•Œ ì§€ì†ì ìœ¼ë¡œ í•™ìŠµí•˜ë©° ì„±ëŠ¥ì˜ ì•ˆì •ì„±ê³¼ ì ì‘ì„±ì„ ì…ì¦í–ˆìŠµë‹ˆë‹¤.


---

*Generated on 2025-09-24 14:51:49*